Scynexis (SCYX) Total Liabilities (2013 - 2026)
Scynexis (SCYX) posted Total Liabilities of $36.3 million for Q1 2026, up 276.32% on a QoQ basis from $9.7 million in Q4 2025, and up 108.93% year-over-year from $17.4 million in Q1 2025.
Scynexis (SCYX) Total Liabilities (2013 - 2026) Analysis & Trends
Scynexis' Total Liabilities history runs 14 years deep, the most recent figure standing at $36.3 million for Q1 2026.
- Quarterly Total Liabilities rose 108.93% year-over-year to $36.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.3 million (up 108.93% YoY) and the FY2025 annual result came in at $9.7 million, down 72.86% from the prior year.
- Total Liabilities was $36.3 million for Q1 2026 at Scynexis, up from $9.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $100.2 million in Q1 2023 and bottomed at $9.7 million in Q4 2025.
- A 5-year average of $51.7 million and a median of $47.4 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2025 — Total Liabilities plunged 72.86% — and 2026, when it jumped 108.93%.
- Scynexis' Total Liabilities stood at $84.6 million in 2022, then slumped by 34.44% to $55.4 million in 2023, then plunged by 35.86% to $35.6 million in 2024, then slumped by 72.86% to $9.7 million in 2025, then surged by 276.32% to $36.3 million in 2026.
- Business Quant data shows SCYX's Total Liabilities at $36.3 million in Q1 2026, $9.7 million in Q4 2025, and $14.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 36.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.32 Mn |
| Dec 31, 2025 | 9.65 Mn |
| Sep 30, 2025 | 14.64 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Mar 31, 2025 | 17.38 Mn |
| Dec 31, 2024 | 35.57 Mn |
| Sep 30, 2024 | 40.51 Mn |
| Jun 30, 2024 | 47.40 Mn |
| Mar 31, 2024 | 44.15 Mn |
| Dec 31, 2023 | 55.45 Mn |
| Sep 30, 2023 | 56.56 Mn |
| Jun 30, 2023 | 61.78 Mn |
| Mar 31, 2023 | 100.21 Mn |
| Dec 31, 2022 | 84.58 Mn |
| Sep 30, 2022 | 95.08 Mn |
| Jun 30, 2022 | 90.13 Mn |
| Mar 31, 2022 | 72.64 Mn |
| Dec 31, 2021 | 78.58 Mn |
| Sep 30, 2021 | 72.27 Mn |
| Jun 30, 2021 | 88.81 Mn |